Acadia Healthcare
ACHC Nasdaq· Health Care Facilities
Last close · Oct 27, 2026
$29.90
KIRA · Stoqly’s AI analyst, in plain words
- Acadia Healthcare had $3.3B of revenue in fiscal 2025, up 5.0% on the year before. Over five years, revenue changed +9.7% a year on average.
- Acadia Healthcare lost $1.1B in fiscal 2025.
- Free cash flow was −$440M in fiscal 2025, −13.3% of revenue.
- Acadia Healthcare returned $50.0M to shareholders in fiscal 2025. The diluted share count fell 1.5%.
- Acadia Healthcare owes $2.4B more than it holds in cash.
Market cap
$2.7B
P/E
—
Revenue
$3.3B
Net income
−$1.1B
Free cash flow
−$440M
Operating margin
—
Acadia Healthcare in 30 seconds · fiscal 2025
Are sales growing?
+5.0%
Yes. Sales grew 5.0% last year.
Does it make a profit?
−33.3%
No. It lost money last year.
Does profit turn into cash?
−13.3%
No. It spent more cash than it brought in.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
What Acadia Healthcare does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 27, 2026
- Legal name
- Acadia Healthcare Company, Inc.
- CIK
- 0001520697
Acadia Healthcare · ACHC
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $2.3B | $2.6B | $2.9B | $3.2B | $3.3B |
| Revenue growth | 10.7% | 12.8% | 12.2% | 7.7% | 5.0% |
| Net income | $191M | $273M | −$21.7M | $256M | −$1.1B |
| Net margin | 8.2% | 10.5% | −0.7% | 8.1% | −33.3% |
| Diluted EPS | $2.10 | $2.98 | −$0.24 | $2.78 | −$12.16 |
| Cash | |||||
| Cash from operations | $375M | $381M | $462M | $130M | $132M |
| Capital expenditure | $245M | $296M | $424M | $690M | $572M |
| Free cash flow | $130M | $84.4M | $38.2M | −$561M | −$440M |
| FCF margin | 5.6% | 3.2% | 1.3% | −17.8% | −13.3% |
| Dividends paid | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $0.0M | $0.0M | $0.0M | $50.0M |
| Share count change | 2.5% | 0.8% | −0.7% | 1.2% | −1.5% |
| Debt and strength | |||||
| Cash and short-term investments | $134M | $97.6M | $100M | $76.3M | $133M |
| Debt incl. finance leases | $1.5B | $1.4B | $1.4B | $2.0B | $2.5B |
| Shareholders' equity | $2.5B | $2.8B | $2.8B | $3.1B | $1.9B |
| Net debt / EBITDA | 2.9x | 2.3x | 6.8x | 3.1x | — |
| Current ratio | 1.2x | 1.3x | 0.7x | 1.0x | 1.6x |
| Interest coverage | 3.9x | 6.7x | 0.7x | 4.0x | −7.6x |
| Returns and quality | |||||
| Return on capital | 6.5% | 8.2% | 1.1% | 7.8% | −16.0% |
| Return on equity | 8.6% | 10.3% | −0.8% | 8.7% | −43.9% |
| Piotroski F-score | 6 | 6 | 5 | 5 | 4 |
| Altman Z'' | 1.8 | 2.3 | 1.0 | 1.9 | −0.7 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Acadia Healthcare · ACHC
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
Similar companies
Each company’s latest fiscal year. Fiscal years end in different months, so periods don’t line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score |
|---|---|---|---|---|---|---|---|
| Acadia Healthcare ACHC | $2.7B | 5.0% | — | −13.3% | −16.0% | — | 4 |
| Astrana Health ASTH | $1.8B | 56.4% | 2.5% | 3.3% | 4.2% | 44.5x | 4 |
| Ensign Group ENSG | $10.1B | 18.7% | 8.4% | — | 19.7% | 26.6x | 6 |
| Option Care Health OPCH | $5.0B | 13.0% | 6.0% | 3.8% | 11.4% | 24.4x | 5 |
| Encompass Health EHC | $12.2B | 10.5% | — | 7.4% | 15.8% | 19.8x | 8 |
KIRA
At $29.90 a share, the company is worth $2.7B.
Acadia Healthcare grew sales faster than 0 of its 4 similar companies.
Source: SEC EDGAR XBRL filings (CIK 0001520697). Data updated October 22, 2026. For information only — not investment advice. Check the original filings before relying on any figure.